Markets › United States › AbbVie
AbbVie (ABBV) share price
286.20 USD +0.94%
NYSE · last price Fri 20 Nov, 16:02 local time · change vs previous close · may be delayed
Why is AbbVie moving?
AbbVie rose 0.94% today to $286.20, but none of the headlines reports a company-specific event that would explain the move. It appears to have come without obvious company-specific news and may reflect the wider market or sector.
- The shares are about 5.5% below their 52-week high of $302.93 and about 50% above the 52-week low of $190.75.
- The stock is up 25.3% year to date and 21.1% over the past year, but down 3.0% over the past week.
- The recent headlines are mostly analysis and commentary, such as a Simply Wall St. piece on a solid tumor partnership and a Motley Fool comparison with Eli Lilly, and none of them states a cause for today's move.
AI-generated from price data and headlines. May contain errors. Not advice.
Open AbbVie in the live dashboard →
AbbVie share price over the past year
Key figures
| Previous close | 283.54 USD |
| Day range | 284.85 – 290.23 |
| 52-week range | 190.75 – 302.93 |
| 1 week | -2.99% |
| 1 month | +0.35% |
| Year to date | +25.26% |
| 1 year | +21.13% |
| Volume | 8.76M |
| Currency | USD |
Latest AbbVie news
- Is Solid Tumor Partnership Altering The Investment Case For AbbVie (ABBV)? Simply Wall St. · 21 Nov
- 5 High-Yield Healthcare Stocks for a Tax-Free Roth IRA Income Stream 24/7 Wall St. · 20 Nov
- AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027? Motley Fool · 20 Nov
- Should You Buy Jazz Pharmaceuticals Stock For Its Cash? Trefis · 20 Nov
- Senate Passes Landmark Permitting Bill. Here’s Who Could Benefit. Barrons.com · 20 Nov
- Oncology Clinical Trials - Global Strategic Business Report 2026: Secure Share of a $6 Billion Revenue Surge by 2032 as AbbVie, AstraZeneca, ICON, Merck, and Roche Accelerate AI-Led Trials GlobeNewswire · 20 Nov
Other big United States stocks
NVIDIA Apple Microsoft Broadcom Oracle AMD Salesforce Cisco IBM ServiceNow Accenture Adobe
General information only, not financial advice. Prices from Yahoo Finance and may be delayed.